Over-the-Counter Drugs Market Projected to Reach USD 213.08 Billion by 2030, Exhibiting a CAGR of 5.93% - Global 2024 Report
November 01, 2024 10:10 ET
|
Research and Markets
Dublin, Nov. 01, 2024 (GLOBE NEWSWIRE) -- The "Over the Counter (OTC) Drugs - Market Insight, Competitive Landscape, and Market Forecast - 2030" report has been added to ResearchAndMarkets.com's...
Saudi Arabia Over The Counter Drugs Market Report 2024-2029F Featuring Key Vendors - Novartis, Pfizer, Glenmark, Sitco, CAD Middle East Pharmaceutical, Sudair, Tabuk, Jamjoom, GSK, and AstraZeneca
September 17, 2024 11:19 ET
|
Research and Markets
Dublin, Sept. 17, 2024 (GLOBE NEWSWIRE) -- The "Saudi Arabia Over The Counter Drugs Market, By Region, Competition, Forecast & Opportunities, 2019-2029F" report has been added to ...
Global Acetaminophen-Opioid Combination Market Growth Accelerating Due to an Impressive USD 4,522.6 Million by 2034 Increased Usage in Cancer-Related Pain: Future Market Insights
August 25, 2024 20:30 ET
|
Future Market Insights Global and Consulting Pvt. Ltd.
NEWARK, Del, Aug. 25, 2024 (GLOBE NEWSWIRE) -- The global acetaminophen-opioid combination market is on a promising trajectory, with expectations to grow from USD 3,144.1 million in 2024 to an...
Analgesics Market Insights, Competitive Landscape and Market Forecast to 2030
August 15, 2024 11:48 ET
|
Research and Markets
Dublin, Aug. 15, 2024 (GLOBE NEWSWIRE) -- The "Analgesics - Market Insights, Competitive Landscape, and Market Forecast - 2030" report has been added to ResearchAndMarkets.com's offering.The...
Global Paracetamol IV Market to reach USD 1,575.45 million by 2030 - By Indication (Pain, Pyrexia/Fever), Application (Non-surgical, Surgical), End-use - Forecast 2024-2030
March 08, 2024 09:34 ET
|
Research and Markets
Dublin, March 08, 2024 (GLOBE NEWSWIRE) -- The "Global Paracetamol IV Market by Indication (Pain, Pyrexia/Fever), Application (Non-surgical, Surgical), End-use - Forecast 2024-2030" report has been...
MAXIGESIC IV Drug Insight and U.S. Market Forecasts to 2032: In-depth Product Overview, Regulatory Milestones, Competitive Landscape Analysis, and SWOT Analysis
January 29, 2024 12:15 ET
|
Research and Markets
Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "United States MAXIGESIC IV Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. Dual Mode-of-Action...
Opioid Market Size, Share & Trends Analysis Report and Segment Forecasts 2023-2030: Recent Developments & Impact Analysis, By Key Market Participants
November 17, 2023 04:33 ET
|
Research and Markets
Dublin, Nov. 17, 2023 (GLOBE NEWSWIRE) -- The "Opioid Market Size, Share & Trends Analysis Report By Product (IR/ Short Acting Opioids, ER/Long-Acting Opioids), By Application, By Route Of...
China Paracetamol Export Report 2023: Export Analysis 2018-2022, Destinations Analysis 2018-2022, Outlook 2023-2032
June 01, 2023 10:58 ET
|
Research and Markets
Dublin, June 01, 2023 (GLOBE NEWSWIRE) -- The "Research Report on China's Paracetamol Export 2023-2032" report has been added to ResearchAndMarkets.com's offering. China is one of the major...
Global $45.38 Billion Analgesics Market Insights, Competitive Landscape, and Market Forecasts, 2022-2023 & 2027
April 18, 2023 10:03 ET
|
Research and Markets
Dublin, April 18, 2023 (GLOBE NEWSWIRE) -- The "Analgesics - Market Insights, Competitive Landscape, and Market Forecast - 2027" report has been added to ResearchAndMarkets.com's offering.The...
Global Acute Migraine Drugs Market Report 2023: A $14.06 Billion Market by 2028 Featuring Key Players - Eli Lilly and Co, GSK, Bayer, J&J, Teva, AbbVie, Novartis, Merck, Pfizer, & Boehringer Ingelheim
March 10, 2023 05:53 ET
|
Research and Markets
Dublin, March 10, 2023 (GLOBE NEWSWIRE) -- The "Global Acute Migraine Drugs Market - Analysis By Drug Type (Ergot Alkaloids, Analgesics, Triptans, Others), Route of Administration, Availability, By...